The 13th edition of BioAsia will be organised with the theme of Leveraging India to Succeed globally and shall focus on connecting the dots to build stakeholder consensus and draw a distinct road-map to propel the sector growth.
Partner Dr Jonathan Atkinon and Patent Director Punita Shah will be attending BIOAsia 2016 which will be held in Hyderabad, India 8th-10th February 2016 at the Hotyel Novotel Hyderabad Convention Centre.
With increasing pressure to reduce drug development costs and accelerate R&D programs, the global companies have started setting up R&D centres in Asia to take advantage of cost-effective, yet highly skilled talent pool. India has emerged as a preferred destination for contract research and manufacturing activities, process reengineering and innovative R&D to act as a single destination with various enablers in place. The country is aided by a large, highly skilled community of scientists and researchers. Additionally, the government’s support in bringing a comprehensive IPR Policy, launch of ‘Make in India’ and financial support programs, regulatory reforms, etc. are expected to further boost the growth for Life Sciences industry.